|
ARGX
|
argenx SE
|
US
|
NASDAQ
|
|
FBIO
|
Fortress Biotech, Inc.
|
US
|
NASDAQ
|
|
FBIOP
|
Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock
|
US
|
NASDAQ
|
|
IMCR
|
Immunocore Holdings plc
|
US
|
NASDAQ
|
|
IMVT
|
Immunovant, Inc.
|
US
|
NASDAQ
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
US
|
NASDAQ
|
|
XNCR
|
Xencor, Inc.
|
US
|
NASDAQ
|
|
24H
|
Hansa Biopharma AB
|
DE
|
F
|
|
3681
|
SinoMab BioScience Ltd
|
HK
|
HK
|
|
9969
|
Innocare Pharma Ltd
|
HK
|
HK
|
|
IVA
|
Inventiva S.A
|
FR
|
PA
|
|
IDOGEN
|
Idogen AB
|
SE
|
ST
|
|
NXTCL
|
NextCell Pharma AB
|
SE
|
ST
|
|
XTLB
|
XTL Biopharmaceuticals Ltd
|
IL
|
TA
|
|
1IJA
|
Adicet Bio Inc
|
DE
|
F
|
|
1K0
|
IGM BIOSCIENCES DL-01
|
DE
|
F
|
|
65G
|
NEXTCELL PHARMA AB
|
DE
|
F
|
|
H2K2
|
XTL Biopharmaceuticals Ltd
|
DE
|
F
|
|
RYH0
|
SAREUM HLDGS LS-0125
|
DE
|
F
|
|
HNSA
|
Hansa Biopharma AB
|
SE
|
ST
|